Coya Therapeutics Inc.

NASDAQ: COYA · Real-Time Price · USD
6.09
0.41 (7.12%)
At close: Aug 15, 2025, 3:59 PM
6.20
1.81%
After-hours: Aug 15, 2025, 07:54 PM EDT

Coya Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-14.88M -7.99M -12.24M -4.89M
Depreciation & Amortization
27.36K 27.36K 27.36K 16.13K
Stock-Based Compensation
2.66M 872.25K 207.35K 233.22K
Other Working Capital
-6.1M 2.56M -93.45K 74K
Other Non-Cash Items
25K 543.19K 4.02M -399.68K
Deferred Income Tax
n/a n/a n/a 399.68K
Change in Working Capital
1.88M -4.64M 751.84K 739.17K
Operating Cash Flow
-10.29M -11.19M -7.24M -3.9M
Capital Expenditures
n/a n/a 4.00 -136.8K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
-25K -543.19K -525K n/a
Investing Cash Flow
-25K -543.19K -525K -136.8K
Debt Repayment
n/a n/a 10.47M n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
2.02M 89.95K -1.11M -341.9K
Financial Cash Flow
16.03M 38.43M 9.36M -340.58K
Net Cash Flow
5.71M 26.69M 1.59M -4.38M
Free Cash Flow
-10.29M -11.19M -7.24M -4.04M